{
  "study_id": "10.1056/NEJMoa1405095",
  "study_title": "Enzalutamide in metastatic prostate cancer before chemotherapy",
  "table_name": "Table S2",
  "table_title": "Demographic and Baseline Patient Characteristics (ITT Population).",
  "footnotes": [
    "Eligibility based on screening values.",
    "* Includes all steroid use for prostate cancer on the date of first dose of study drug and with continuous exposure for at least 7 days.",
    "† History of prior cardiovascular disease is based on medical history.",
    "BPI-SF denotes Brief Pain Inventory Short Form, ECOG Eastern Cooperative Oncology Group, ITT intent-to-treat, PSA prostate-specific antigen."
  ],
  "groups": [
    {
      "name": "Enzalutamide",
      "n": 872,
      "type": "Intervention"
    },
    {
      "name": "Placebo",
      "n": 845,
      "type": "Control"
    }
  ],
  "characteristics": [
    {
      "original_label": "Age",
      "standardized_name": "Age",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Age",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 72.0,
          "raw_string": "72.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 71.0,
          "raw_string": "71.0"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Age",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 43.0,
          "range_max": 93.0,
          "raw_string": "43.0-93.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 42.0,
          "range_max": 93.0,
          "raw_string": "42.0-93.0"
        }
      ]
    },
    {
      "original_label": "Age category – years, no. (%)",
      "standardized_name": "Age category",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "<65",
      "standardized_name": "Age category",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age category – years, no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 179.0,
          "percentage": 20.5,
          "raw_string": "179 (20.5)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 179.0,
          "percentage": 21.2,
          "raw_string": "179 (21.2)"
        }
      ]
    },
    {
      "original_label": "65 to 74",
      "standardized_name": "Age category",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age category – years, no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 376.0,
          "percentage": 43.1,
          "raw_string": "376 (43.1)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 374.0,
          "percentage": 44.3,
          "raw_string": "374 (44.3)"
        }
      ]
    },
    {
      "original_label": "≥75 to 84",
      "standardized_name": "Age category",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age category – years, no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 274.0,
          "percentage": 31.4,
          "raw_string": "274 (31.4)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 240.0,
          "percentage": 28.4,
          "raw_string": "240 (28.4)"
        }
      ]
    },
    {
      "original_label": "≥85",
      "standardized_name": "Age category",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age category – years, no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 43.0,
          "percentage": 4.9,
          "raw_string": "43 (4.9)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 52.0,
          "percentage": 6.2,
          "raw_string": "52 (6.2)"
        }
      ]
    },
    {
      "original_label": "Race - no. (%)",
      "standardized_name": "Race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "American Indian or Alaska Native",
      "standardized_name": "Race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.1,
          "raw_string": "1 (0.1)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "raw_string": "0"
        }
      ]
    },
    {
      "original_label": "Asian",
      "standardized_name": "Race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 85.0,
          "percentage": 9.7,
          "raw_string": "85 (9.7)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 82.0,
          "percentage": 9.7,
          "raw_string": "82 (9.7)"
        }
      ]
    },
    {
      "original_label": "Black or African American",
      "standardized_name": "Race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 21.0,
          "percentage": 2.4,
          "raw_string": "21 (2.4)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 13.0,
          "percentage": 1.5,
          "raw_string": "13 (1.5)"
        }
      ]
    },
    {
      "original_label": "Native Hawaiian or other Pacific Islander",
      "standardized_name": "Race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.1,
          "raw_string": "1 (0.1)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.1,
          "raw_string": "1 (0.1)"
        }
      ]
    },
    {
      "original_label": "White",
      "standardized_name": "Race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 669.0,
          "percentage": 76.7,
          "raw_string": "669 (76.7)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 655.0,
          "percentage": 77.5,
          "raw_string": "655 (77.5)"
        }
      ]
    },
    {
      "original_label": "Other, multiple, unknown",
      "standardized_name": "Race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 95.0,
          "percentage": 10.9,
          "raw_string": "95 (10.9)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 94.0,
          "percentage": 11.1,
          "raw_string": "94 (11.1)"
        }
      ]
    },
    {
      "original_label": "Ethnicity - no. (%)",
      "standardized_name": "Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Not Hispanic or Latino",
      "standardized_name": "Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Ethnicity - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 784.0,
          "percentage": 89.9,
          "raw_string": "784 (89.9)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 743.0,
          "percentage": 87.9,
          "raw_string": "743 (87.9)"
        }
      ]
    },
    {
      "original_label": "Hispanic or Latino",
      "standardized_name": "Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Ethnicity - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 16.0,
          "percentage": 1.8,
          "raw_string": "16 (1.8)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 22.0,
          "percentage": 2.6,
          "raw_string": "22 (2.6)"
        }
      ]
    },
    {
      "original_label": "Not reported, unknown",
      "standardized_name": "Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Ethnicity - no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 72.0,
          "percentage": 8.3,
          "raw_string": "72 (8.3)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 80.0,
          "percentage": 9.5,
          "raw_string": "80 (9.5)"
        }
      ]
    },
    {
      "original_label": "Baseline weight – kg",
      "standardized_name": "Weight",
      "unit": "kg",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "No.",
      "standardized_name": "Sample size",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline weight – kg",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 870.0,
          "raw_string": "870"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 844.0,
          "raw_string": "844"
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Weight",
      "unit": "kg",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline weight – kg",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 83.1,
          "raw_string": "83.1"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 82.8,
          "raw_string": "82.8"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Weight",
      "unit": "kg",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline weight – kg",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 48.9,
          "range_max": 162.2,
          "raw_string": "48.9-162.2"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 33.9,
          "range_max": 160.2,
          "raw_string": "33.9-160.2"
        }
      ]
    },
    {
      "original_label": "Body mass index – kg/m²",
      "standardized_name": "Body mass index",
      "unit": "kg/m^2",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "No.",
      "standardized_name": "Sample size",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Body mass index – kg/m²",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 870.0,
          "raw_string": "870"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 843.0,
          "raw_string": "843"
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Body mass index",
      "unit": "kg/m^2",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Body mass index – kg/m²",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 27.5,
          "raw_string": "27.5"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 27.5,
          "raw_string": "27.5"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Body mass index",
      "unit": "kg/m^2",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Body mass index – kg/m²",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 17.5,
          "range_max": 46.8,
          "raw_string": "17.5-46.8"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 15.3,
          "range_max": 50.6,
          "raw_string": "15.3-50.6"
        }
      ]
    },
    {
      "original_label": "Baseline ECOG performance status no. (%)",
      "standardized_name": "ECOG performance status",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "ECOG performance status",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline ECOG performance status no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 584.0,
          "percentage": 67.0,
          "raw_string": "584 (67.0)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 585.0,
          "percentage": 69.2,
          "raw_string": "585 (69.2)"
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "ECOG performance status",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline ECOG performance status no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 288.0,
          "percentage": 33.0,
          "raw_string": "288 (33.0)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 260.0,
          "percentage": 30.8,
          "raw_string": "260 (30.8)"
        }
      ]
    },
    {
      "original_label": "≥2",
      "standardized_name": "ECOG performance status",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline ECOG performance status no. (%)",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "raw_string": "0"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "raw_string": "0"
        }
      ]
    },
    {
      "original_label": "Baseline mean pain score BPI-SF question 3",
      "standardized_name": "Baseline mean pain score (BPI-SF)",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "No.",
      "standardized_name": "Sample size",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline mean pain score BPI-SF question 3",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 859.0,
          "raw_string": "859"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 840.0,
          "raw_string": "840"
        }
      ]
    },
    {
      "original_label": "0 to 1 - no. (%)",
      "standardized_name": "Baseline mean pain score (BPI-SF)",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline mean pain score BPI-SF question 3",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 569.0,
          "percentage": 66.2,
          "raw_string": "569 (66.2)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 567.0,
          "percentage": 67.5,
          "raw_string": "567 (67.5)"
        }
      ]
    },
    {
      "original_label": "2 to 3 - no. (%)",
      "standardized_name": "Baseline mean pain score (BPI-SF)",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline mean pain score BPI-SF question 3",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 275.0,
          "percentage": 32.0,
          "raw_string": "275 (32.0)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 262.0,
          "percentage": 31.2,
          "raw_string": "262 (31.2)"
        }
      ]
    },
    {
      "original_label": ">3 - no. (%)",
      "standardized_name": "Baseline mean pain score (BPI-SF)",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline mean pain score BPI-SF question 3",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 15.0,
          "percentage": 1.7,
          "raw_string": "15 (1.7)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 11.0,
          "percentage": 1.3,
          "raw_string": "11 (1.3)"
        }
      ]
    },
    {
      "original_label": "Baseline hemoglobin – g/L",
      "standardized_name": "Hemoglobin",
      "unit": "g/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Hemoglobin",
      "unit": "g/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline hemoglobin – g/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 130.0,
          "raw_string": "130.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 131.0,
          "raw_string": "131.0"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Hemoglobin",
      "unit": "g/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline hemoglobin – g/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 82.0,
          "range_max": 168.0,
          "raw_string": "82.0-168.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 74.0,
          "range_max": 167.0,
          "raw_string": "74.0-167.0"
        }
      ]
    },
    {
      "original_label": "Baseline alkaline phosphatase – U/L",
      "standardized_name": "Alkaline phosphatase",
      "unit": "U/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Alkaline phosphatase",
      "unit": "U/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline alkaline phosphatase – U/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 94.0,
          "raw_string": "94.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 86.0,
          "raw_string": "86.0"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Alkaline phosphatase",
      "unit": "U/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline alkaline phosphatase – U/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 34.0,
          "range_max": 4485.0,
          "raw_string": "34.0-4485.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 27.0,
          "range_max": 2350.0,
          "raw_string": "27.0-2350.0"
        }
      ]
    },
    {
      "original_label": "Baseline lactate dehydrogenase – U/L",
      "standardized_name": "Lactate dehydrogenase",
      "unit": "U/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "No.",
      "standardized_name": "Sample size",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline lactate dehydrogenase – U/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 871.0,
          "raw_string": "871"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 844.0,
          "raw_string": "844"
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Lactate dehydrogenase",
      "unit": "U/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline lactate dehydrogenase – U/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 185.0,
          "raw_string": "185.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 185.0,
          "raw_string": "185.0"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Lactate dehydrogenase",
      "unit": "U/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline lactate dehydrogenase – U/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 52.0,
          "range_max": 1861.0,
          "raw_string": "52.0-1861.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 67.0,
          "range_max": 2321.0,
          "raw_string": "67.0-2321.0"
        }
      ]
    },
    {
      "original_label": "Baseline serum albumin – g/L",
      "standardized_name": "Serum albumin",
      "unit": "g/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Serum albumin",
      "unit": "g/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline serum albumin – g/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 38.0,
          "raw_string": "38.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 39.0,
          "raw_string": "39.0"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Serum albumin",
      "unit": "g/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline serum albumin – g/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 25.0,
          "range_max": 48.0,
          "raw_string": "25.0-48.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 28.0,
          "range_max": 49.0,
          "raw_string": "28.0-49.0"
        }
      ]
    },
    {
      "original_label": "Baseline serum PSA – µg/L",
      "standardized_name": "Serum PSA",
      "unit": "µg/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "No.",
      "standardized_name": "Sample size",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline serum PSA – µg/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 872.0,
          "raw_string": "872"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 844.0,
          "raw_string": "844"
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Serum PSA",
      "unit": "µg/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline serum PSA – µg/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 54.1,
          "raw_string": "54.1"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 44.2,
          "raw_string": "44.2"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Serum PSA",
      "unit": "µg/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline serum PSA – µg/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 0.1,
          "range_max": 3182.0,
          "raw_string": "0.1-3182.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 0.3,
          "range_max": 3637.0,
          "raw_string": "0.3-3637.0"
        }
      ]
    },
    {
      "original_label": "Baseline creatinine – µmol/L",
      "standardized_name": "Creatinine",
      "unit": "µmol/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Placebo",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Creatinine",
      "unit": "µmol/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline creatinine – µmol/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_single",
          "value": 85.0,
          "raw_string": "85.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_single",
          "value": 87.0,
          "raw_string": "87.0"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Creatinine",
      "unit": "µmol/L",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Baseline creatinine – µmol/L",
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "numeric_mean_range",
          "range_min": 29.0,
          "range_max": 207.0,
          "raw_string": "29.0-207.0"
        },
        {
          "group_name": "Placebo",
          "data_type": "numeric_mean_range",
          "range_min": 41.0,
          "range_max": 218.0,
          "raw_string": "41.0-218.0"
        }
      ]
    },
    {
      "original_label": "Baseline use of corticosteroids >7 days* – no. (%)",
      "standardized_name": "Baseline corticosteroid use >7 days",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 35.0,
          "percentage": 4.0,
          "raw_string": "35 (4.0)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 36.0,
          "percentage": 4.3,
          "raw_string": "36 (4.3)"
        }
      ]
    },
    {
      "original_label": "History of cardiovascular disease† – no. (%)",
      "standardized_name": "History of cardiovascular disease",
      "category": "Baseline Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Enzalutamide",
          "data_type": "categorical_count_percentage",
          "count": 179.0,
          "percentage": 20.5,
          "raw_string": "179 (20.5)"
        },
        {
          "group_name": "Placebo",
          "data_type": "categorical_count_percentage",
          "count": 168.0,
          "percentage": 19.9,
          "raw_string": "168 (19.9)"
        }
      ]
    }
  ]
}